A Flint woman may be the first in the world with leukemia to undergo a transplant using stem cells from the bone marrow of a ...

In both lymphoma and leukemia, the symptoms overlap. A patient is likely to undergo weight loss and experience fatigue in ...

Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

Each type of white blood cell has a specific job. Some spot intruders and kill harmful bacteria. Others make antibodies to ...

Navitoclax dihydrochloride is a small molecule commercialized by AbbVie, with a leading Phase III program in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF).

CD30 is under clinical development by Wuhan Bio-Raid Biotechnology and currently in Phase I for T-Cell Leukemia.

Survivors' Exposure To Toxic Dust And The Chronic Health Conditions That Followed Offer Lessons That Are Still Too Often ...